Methylprednisolone sodium succinate reduces BBB disruption and inflammation in a model mouse of intracranial haemorrhage
Highlights • MPSS treatment after ICH reduces BBB disruption and brain oedema. • MPSS also inhibits production of inflammatory cytokines and inflammation in the brain. • MPSS reduces apoptosis in the brain, perhaps by decreasing Bax and increasing Bcl-2. • This suggests that MPSS may be a useful tre...
Gespeichert in:
Veröffentlicht in: | Brain research bulletin 2016-10, Vol.127, p.226-233 |
---|---|
Hauptverfasser: | , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Highlights • MPSS treatment after ICH reduces BBB disruption and brain oedema. • MPSS also inhibits production of inflammatory cytokines and inflammation in the brain. • MPSS reduces apoptosis in the brain, perhaps by decreasing Bax and increasing Bcl-2. • This suggests that MPSS may be a useful treatment for ICH and result in improved patient prognosis. |
---|---|
ISSN: | 0361-9230 1873-2747 |
DOI: | 10.1016/j.brainresbull.2016.10.007 |